RAS inhibitors: how a pancreatic cancer pill works

12 steps · about 2 h 24 min · Beginner

  1. Understanding Cancer (guide, National Cancer Institute, 15 min)

    Start with the core idea that cancer is a disease of the genes that control how cells behave.

  2. The Genetics of Cancer (article, National Cancer Institute, 15 min)

    It shows how random DNA changes pile up over time and turn healthy cells cancerous.

  3. How Genetic Changes Lead to Cancer (article, National Cancer Institute, 8 min)

    It links genes to proteins and shows how a single mutation can change a protein's function, which is what happens to RAS.

  4. Cell Biology of Cancer (article, SEER Training Modules, 20 min)

    It introduces oncogenes and tumor suppressors, so you know why a stuck-on switch like RAS is dangerous.

  5. KRAS and Lung Cancer (article, American Lung Association, 10 min)

    A plain-language look at what KRAS does as a cell-growth signal hub and how mutations are tested for.

  6. Targeted Therapy (article, American Cancer Society, 15 min)

    It explains how drugs aimed at specific cancer features differ from chemotherapy.

  7. FDA Approves Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancer (article, WebMD, 8 min)

    A patient-level summary of what the pill is, who it is for and how it differs from IV chemotherapy.

  8. New pancreatic cancer drug daraxonrasib shows breakthrough in survival (article, UCHealth Today, 8 min)

    It explains in simple terms why RAS has been a hard target and why this drug is the first of a new class.

  9. Oncology Drug Reference Sheet: Daraxonrasib (reference, Oncology Nursing Society, 10 min)

    It gives the molecular mechanism: the drug binds cyclophilin A, and that complex locks onto active RAS.

  10. Dr Aguirre on Daraxonrasib Bringing RAS-Targeted Therapy to Pancreatic Cancer (article, Targeted Oncology, 10 min)

    A researcher explains the molecular-glue idea and the path from preclinical work to phase 3.

  11. How to Read Cancer Trial Results: Survival Terms Explained (article, CURE Today, 10 min)

    It teaches trial phases, median survival, progression-free survival and hazard ratios before you read the real paper.

  12. How to Read a Clinical Trial: Hazard Ratios and Kaplan-Meier Curves (article, FTLO Science, 15 min)

    It deepens your statistics skills with survival curves and the limits of hazard ratios.